Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Real-Time Monitoring of Critical Process Parameters – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Real-Time Monitoring of Critical Process Parameters – V 2.0

Standard Operating Procedure for Real-Time Monitoring of Critical Process Parameters


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/077/2025
Supersedes SOP/SIM/077/2022
Page No. Page 1 of 13
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the procedure for real-time monitoring of critical process parameters (CPPs) during sterile injectable manufacturing to ensure consistent control and product quality in accordance with GMP, WHO, and ICH guidelines.

2. Scope

This SOP is applicable to all

sterile manufacturing areas where critical process parameters like temperature, pressure, humidity, filling volume, and sterilization cycles are monitored during the production of sterile injectable products.

3. Responsibilities

  • Production Operator: Performs operations and ensures adherence to prescribed parameters.
  • Engineering Staff: Maintains instrumentation and monitoring systems.
  • QA Officer: Reviews data and ensures documentation compliance.
See also  Quality Control: SOP for Periodic Calibration of QC Equipment - V 2.0

4. Accountability

Head – Manufacturing is accountable for ensuring implementation and adherence to real-time monitoring requirements and timely response to deviations.

5. Procedure

5.1 Identification of Critical Process Parameters

  1. List CPPs based on product-specific risk assessments, process validation, and regulatory filings.
  2. Typical parameters include:
    • Autoclave cycle temperature and pressure
    • Filling speed and volume accuracy
    • Reactor vessel temperature
    • Compressed air quality (dew point, pressure)
    • HEPA filter differential pressure

5.2 Real-Time Monitoring Systems

  1. Ensure use of validated SCADA systems or DCS with 21 CFR Part 11 compliance.
  2. Each CPP should be linked to alarms and interlocks where applicable.
  3. All data must be backed up and archived with proper access control.

5.3 Monitoring During Manufacturing

  1. Verify that sensors, transmitters, and software are calibrated and functional before batch initiation.
  2. Record real-time data continuously or at defined intervals depending on parameter criticality.
  3. Use the Critical Parameter Monitoring Log (Annexure-1) for manual recording, if applicable.
See also  Sterile Injectable Manufacturing: SOP for Managing Equipment Breakdowns in Manufacturing - V 2.0

5.4 Review and Action on Out-of-Range Data

  1. If any CPP deviates from limits:
    • Alert must be acknowledged immediately.
    • Investigate root cause and assess product impact.
    • Initiate deviation (Annexure-2) and inform QA.

5.5 Documentation and Archival

  1. Ensure all records (automated and manual) are signed and reviewed.
  2. Attach parameter trend charts with BMR for each batch.
  3. Archive data for a minimum of 5 years or as per regulatory requirement.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • CPP: Critical Process Parameter
  • SCADA: Supervisory Control and Data Acquisition
  • DCS: Distributed Control System
  • BMR: Batch Manufacturing Record

7. Documents

  1. Critical Parameter Monitoring Log – Annexure-1
  2. Deviation Report Form – Annexure-2
  3. Parameter Trend Summary Sheet – Annexure-3

8. References

  • ICH Q8 – Pharmaceutical Development
  • 21 CFR Part 211 – Current Good Manufacturing Practice
  • WHO TRS 986 Annex 2 – GMP for Sterile Pharmaceutical Products
See also  Sterile Injectable Manufacturing: SOP for Stability Testing during Product Development - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Critical Parameter Monitoring Log

Date Parameter Set Value Observed Status Operator Initials
18/06/2025 Filling Volume (ml) 1.00 1.01 OK RS

Annexure-2: Deviation Report Form

Date Deviation ID Description Root Cause Corrective Action QA Remarks
17/06/2025 DEV-1021 Temperature spike in holding tank Sensor lag Sensor replaced Reviewed

Annexure-3: Parameter Trend Summary Sheet

Batch No. Parameter Min Max Mean Trend Observed
INJ-150625 Filling Volume 0.98 1.02 1.00 Stable

Revision History

Revision Date Revision No. Details Reason Approved By
02/01/2022 1.0 Initial Release New SOP QA Head
18/06/2025 2.0 Inclusion of trend analysis sheet and parameter alarm linkages Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Conducting Long-Term Stability Studies on Gels – V 2.0
Next Post: Elixir Department: SOP for Cleaning Validation of Manufacturing Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version